Saturday, December 07, 2024

  • Twitter

August 1, 2024 5:26 PM

Lilly says weight loss drug cut heart failure risk by 38% in trial

Trial results show Eli Lilly's weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure, the company said on Thursday as it continues to build a case for the medicati...

Visitors: 2965790

Last updated on: 7th December 2024